146 related articles for article (PubMed ID: 29593284)
21. Transforming growth factor-beta1 is a potent inhibitor of secretory leukoprotease inhibitor expression in a bronchial epithelial cell line. Munich Lung Transplant Group.
Jaumann F; Elssner A; Mazur G; Dobmann S; Vogelmeier C
Eur Respir J; 2000 Jun; 15(6):1052-7. PubMed ID: 10885424
[TBL] [Abstract][Full Text] [Related]
22. The Estrogen-Induced miR-19 Downregulates Secretory Leucoprotease Inhibitor Expression in Monocytes.
McKiernan PJ; Smith SGJ; Durham AL; Adcock IM; McElvaney NG; Greene CM
J Innate Immun; 2020; 12(1):90-102. PubMed ID: 31266011
[TBL] [Abstract][Full Text] [Related]
23. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.
Zhang Y; DeWitt DL; McNeely TB; Wahl SM; Wahl LM
J Clin Invest; 1997 Mar; 99(5):894-900. PubMed ID: 9062347
[TBL] [Abstract][Full Text] [Related]
24. The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells.
Simpkins FA; Devoogdt NM; Rasool N; Tchabo NE; Alejandro EU; Kamrava MM; Kohn EC
Carcinogenesis; 2008 Mar; 29(3):466-72. PubMed ID: 17916899
[TBL] [Abstract][Full Text] [Related]
25. Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.
Maruyama M; Hay JG; Yoshimura K; Chu CS; Crystal RG
J Clin Invest; 1994 Jul; 94(1):368-75. PubMed ID: 7913712
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases.
Wex T; Treiber G; Venerito M; Leodolter A; Peitz U; Kuester D; Hritz I; Krueger S; Roessner A; Malfertheiner P
Biol Chem; 2006 Jul; 387(7):893-901. PubMed ID: 16913839
[TBL] [Abstract][Full Text] [Related]
27. Adenoviral E1A suppresses secretory leukoprotease inhibitor and elafin secretion in human alveolar epithelial cells and bronchial epithelial cells.
Higashimoto Y; Yamagata Y; Iwata T; Ishiguchi T; Okada M; Masuda M; Satoh H; Itoh H
Respiration; 2005; 72(6):629-35. PubMed ID: 16355004
[TBL] [Abstract][Full Text] [Related]
28. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family.
Moreau T; Baranger K; Dadé S; Dallet-Choisy S; Guyot N; Zani ML
Biochimie; 2008 Feb; 90(2):284-95. PubMed ID: 17964057
[TBL] [Abstract][Full Text] [Related]
29. Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-κB signaling pathway.
Mikami Y; Iwase T; Komiyama Y; Matsumoto N; Oki H; Komiyama K
Mol Immunol; 2015 Oct; 67(2 Pt B):568-74. PubMed ID: 26239418
[TBL] [Abstract][Full Text] [Related]
30. Enhancing the developmental competence of the early embryo using secretory leukocyte peptidase inhibitor.
Kim HS; Ha KS; Kwon HC; Lee SJ; Kim CH; Cheon YP
Differentiation; 2016; 92(1-2):24-34. PubMed ID: 26927923
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of secretory leukocyte proteinase inhibitor in chronic obstructive lung disease: the role of TGF-beta/Smads signaling pathways.
Luo BL; Niu RC; Feng JT; Hu CP; Xie XY; Ma LJ
Arch Med Res; 2008 May; 39(4):388-96. PubMed ID: 18375249
[TBL] [Abstract][Full Text] [Related]
32. Efficient production of the C-terminal domain of secretory leukoprotease inhibitor as a thrombin-cleavable fusion protein in Escherichia coli.
Masuda K; Kamimura T; Kanesaki M; Ishii K; Imaizumi A; Sugiyama T; Suzuki Y; Ohtsuka E
Protein Eng; 1996 Jan; 9(1):101-6. PubMed ID: 9053897
[TBL] [Abstract][Full Text] [Related]
33. Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells.
Abbinante-Nissen JM; Simpson LG; Leikauf GD
Am J Physiol; 1995 Apr; 268(4 Pt 1):L601-6. PubMed ID: 7733301
[TBL] [Abstract][Full Text] [Related]
34. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
[TBL] [Abstract][Full Text] [Related]
35. The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity.
McGarry N; Greene CM; McElvaney NG; Weldon S; Taggart CC
J Immunol Res; 2015; 2015():507315. PubMed ID: 26247039
[TBL] [Abstract][Full Text] [Related]
36. Interaction of secretory leukocyte protease inhibitor with proteinase-3.
Rao NV; Marshall BC; Gray BH; Hoidal JR
Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709
[TBL] [Abstract][Full Text] [Related]
37. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis.
Cox SW; Rodriguez-Gonzalez EM; Booth V; Eley BM
J Periodontal Res; 2006 Oct; 41(5):477-85. PubMed ID: 16953825
[TBL] [Abstract][Full Text] [Related]
38. Regulation and activity of secretory leukoprotease inhibitor (SLPI) is altered in smokers.
Meyer M; Bauer RN; Letang BD; Brighton L; Thompson E; Simmen RC; Bonner J; Jaspers I
Am J Physiol Lung Cell Mol Physiol; 2014 Feb; 306(3):L269-76. PubMed ID: 24285265
[TBL] [Abstract][Full Text] [Related]
39. Secretory leukocyte protease inhibitor promotes differentiation and mineralization of MC3T3-E1 preosteoblasts on a titanium surface.
Choi BD; Lee SY; Jeong SJ; Lim DS; Cha HJ; Chung WG; Jeong MJ
Mol Med Rep; 2016 Aug; 14(2):1241-6. PubMed ID: 27279420
[TBL] [Abstract][Full Text] [Related]
40. Secretory Leukocyte Protease Inhibitor (SLPI) expression downregulates E-cadherin, induces β-catenin re-localisation and triggers apoptosis-related events in breast cancer cells.
Rosso M; Lapyckyj L; Amiano N; Besso MJ; Sánchez M; Chuluyan E; Vazquez-Levin MH
Biol Cell; 2014 Sep; 106(9):308-22. PubMed ID: 25039920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
